Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in Taiwan

NCT06052800 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
78
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Sanofi